BACE1 and Alzheimer disease: Also, ImagMol, which depends on depictions of molecules, performed better results on AD targets such as G protein-coupled receptors (GPCRs), beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), and kinases [162,184].